Updated on 8 August 2012
Our existing products may be expensive for the region, so fundamentally we have to set up a platform that allows cost-effective solutions. Our idea is to bring medical devices that are cost-effective and simple and create devices that allow accessible and affordable care with appropriate technology. When you have an established healthcare system and there is infrastructure in the US and Europe, it is easy to extend operations in new countries.
What medical devices and technology will you focus on?
We are going to do market research in China, India, Indonesia and Singapore and get to know what solutions are viable here. We have narrowed down some products that we are going to manufacture. The Greatbatch Singapore AIMD R&D Center will focus on the design and development of active implantable medical devices, to serve the cardiovascular and neuromodulation markets. The new products will be designed as per the need of Asian market, with low price aspect and easy to use.
To serve the cardiovascular market, the company has identified needs in interventional procedures, atrial fibrillation, MRI conditional systems, as well as targeting health conditions related to cardiovascular disease with therapies for obesity and obstructive sleep apnea.
Our motive is to design the product as per the demand of the region and make it simpler and affordable. We are looking to design it in a different way that gives the same therapy at low costs. This cannot be done by sitting in the US or Europe but has to be done through consultations with healthcare professionals. We will go through regulatory approval of each targeted country in Asia and then launch our products.